Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis - A single centre experience

British Journal of Haematology

Volumn 124, Issue 6, 2004, Pages 762-768

  Zeiser, Robert ^a,c   Burger, Jan A ^a   Bley, Thorsten A ^a   Windfuhr Blum, Marissa ^a   Schulte Mönting, Jürgen ^a   Behringer, Dirk M ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b Augusta Kranken Anstalt   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cerebrospinal fluid; Immunocytology; Magnetic resonance imaging; Neoplastic meningitis; Sensitivity specificity

Indexed keywords

GADOLINIUM PENTETATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CYTODIAGNOSIS; CANCER DIAGNOSIS; CARCINOMATOUS MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; IMMUNOCYTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SOLID TUMOR; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKEMIC INFILTRATION; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MENINGES; MENINGITIS; MIDDLE AGED;

EID: 1642329753     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2004.04853.x     Document Type: Article

References (32)

1. Balm, M. & Hammack, J. (1996) Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Archives of Neurology, 53, 626-632.
2. Boogerd, W., Vroom, T.M., van Heerde, P., Brutel de la Riviere, G., Peterse, J.L. & van der Sande, J.J. (1988) CSF cytology versus immunocytochemistry in meningeal carcinomatosis. Journal of Neurology, Neurosurgery, and Psychiatry, 51, 142-145.
3. Boogerd, W., Hart, A.A. & van der Sande, J.J. (1995) Meningeosis carcinomatosis in breast cancer: prognostic factors and influence of treatment. Cancer, 67, 1685-1695.
4. Bross, K.J., Pangalis, G.A., Staatz, C.G. & Blume, K.G. (1978) Demonstration of cell surface antigens and their antibodies by peroxidase-antiperoxidase method. Transplantation, 25, 331-334.
5. Coakham, H.B., Brownell, B. & Harper, E.L. (1984) Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid. Lancet, 1, 1095-1097.
6. Coiffier, B. (1999) Treatment of aggressive non-Hodgkin's lymphoma. Seminars in Oncology, 26(Suppl. 14), 12-20.
7. DeAngelis, L.M. (1998) Current diagnosis and treatment of leptomeningeal metastasis. Journal of Neuro-oncology, 38, 245-252.
8. Freilich, R.J., Krol, G. & De Angelis, L.M. (1995) Neuroimaging and CSF cytology in the diagnosis of leptomeningeal metastasis. Annals of Neurology, 38, 51-57.
9. Glass, J.P., Mlamed, M. & Chernik, N.L. (1979) Malignant cells in the cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology, 29, 1369-1375.
10. Grossrian, S.A., Finkelstein, D.M., Ruckdeschel, J.C., Trump, D.L., Moynihan, T. & Ettinger, D.S. (1993) Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Journal of Clinical Oncology, 11, 561-569.
11. Hoelzer, D. & Gökbuget, N. (2000) New approaches to acute lymphoblastic leukemia in adults: where do we go? Seminars in Oncology, 27, 540-559.
12. Hosmer, D.W. & Lemeshow, S. (1989) Applied Logistic Regression. Wiley, New York.
13. Hovestadt, A., Henzen-Logmans, S.C. & Vecht, C.J. (1990) Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis. British Journal of Cancer, 62, 653-654.
14. Hsu, S., Raine, L. & Fanger, H. (1981) Use of avidin-biotin- peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry and Cytochemistry, 29, 577-580.
15. Kallmes, D.F., Gray, L. & Glass, J.P. (1998) High-dose gadolinium-enhanced MRI for diagnosis of meningeal metastases. Neuroradiology, 40, 23-26.
16. Kranz, B.R. (2000) Detection of rare malignant cells and their apoptotic fragment in cerebrospinal fluid. Lancet, 356, 1242-1244.
17. Kranz, B.R. & Thierfelder, S. (1993) Optimized detection of cytoplasmatic immunoglobulin and CD3 in benign and malignant lymphoid cells: enhanced sensitivity combined with differential staining of endogenous peroxidases and light microscopic morphology. Journal of Histochemistry and Cytochemistry, 41, 1003-1011.
18. Kranz, B.R., Thiel, E. & Thierfelder, S. (1989) Immunocytochemical identification of meningeal leukemia and lymphoma: poly-L-lysine-coated slides permit multimarker analysis even with minute cerebrospinal fluid cell specimens. Blood, 73, 1942-1950.
19. Olson, M.E., Chernik, N.L. & Posner, J.B. (1974) Infiltration of the leptomeninges by systemic cancer. A clinical and pathologic study. Archives of Neurology, 30, 122-137.
20. van Oostenbrugge, R.J. & Twijnstra, A. (1999) Presenting features and value of diagnostic procedures in leptomeningeal metastases. Neurology, 53, 382.
21. van Oostenbrugge, R.J., Hopman, A.H., Arends, J.W., Ramaekers, F.C. & Twijnstra, A. (2000) Treatment of leptomeningeal metastases evaluated by interphase cytogenetics. Journal of Clinical Oncology, 18, 2053-2058.
22. Pakko, E., Patronas, N.J. & Schellinger, D. (1990) Meningeal Gd-DPTA enhancement in patients with malignancies. Journal of Computer Assisted Tomography, 14, 542-546.
23. Phillips, M.E., Ryals, T.J., Kambhu, S.A. & Yuh, W.T. (1990) Neoplastic vs inflammatory meningeal enhancement with Gd-DTPA. Journal of Computer Assisted Tomography, 14, 536-541.
24. Posner, J.B. (1995) Neurologic Complications of Cancer. F.A. Davis, Philadelphia, PA, pp. 143-171.
25. Posner, J.B. & Chernik, N.L. (1978) Intracranial metastases from systemic cancer. Advances in Neurology, 19, 579-592.
26. Sagar, S.M. (2002) Carcinomatous meningitis: it does not have to be a death sentence. Oncology, 16, 237-243.
27. Shapiro, W.R., Posner, J.B., Ushio, Y., Chemik, N.L. & Young, D.F. (1977) Treatment of meningeal neoplasms. Cancer Treatment Report, 61, 733-743.
28. Straathof, C.S.M., de Bruin, H.G., Dippel, D.W.J. & Vecht, C.J. (1999) The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. Journal of Neurology, 246, 810-814.
29. Sze, G., Soletsky, S., Bronen, R. & Krol, G. (1989) MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. American Journal of Neuroradiology, 10, 965-976.
30. Tani, E., Costa, I., Svedmyr, E. & Skoog, L. (1995) Diagnosis of lymphoma, leukemia and metastatic tumor involvement of the cerebral spinal fluid by cytology and immunocytochemistry. Diagnostic Cytopathology, 12, 12-22.
31. Wasserstrom, W.R., Glass, J.P. & Posner, J.B. (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer, 49, 759-772.
32. van Zanten, A.P., Twijnstra, A., Ongerboer de Visser, B.W., van Heerde, P., Hart, A.A. & Nooyen, W.J. (1991) Cerebrospinal fluid tumor markers in patients treated for meningeal malignancy. Journal of Neurology, Neurosurgery, and Psychiatry, 54, 119-123.